Eidelman Virant Capital Ardelyx, Inc. Transaction History

Eidelman Virant Capital

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$0.51 - $1.17 $7,650 - $17,550	-15,000 Closed	0 $0
Q1 2022 Apr 12, 2022	SELL	$0.65 - $1.18 $3,900 - $7,080	-6,000 Reduced 28.57%	15,000 $16,000
Q4 2021 Feb 01, 2022	BUY	$0.86 - $1.7 $5,160 - $10,200	6,000 Added 40.0%	21,000 $23,000
Q2 2021 Jul 19, 2021	BUY	$6.55 - $8.98 $98,250 - $134,700	15,000 New	15,000 $114,000

218

141M

1.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $799M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Eidelman Virant Capital, based on Form 13F filings with the SEC.

Stay updated on Eidelman Virant Capital with notifications on news.